Viral Vector Manufacturing Market Size, Share, and Growth Forecast, 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Viral Vector Manufacturing Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Application Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Tool Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. PESTLE Analysis
   5. Porter’s Five Force Analysis
4. Price Analysis, 2024A
   1. Key Highlights
   2. Key Factors Impacting Deployment Costs
   3. Pricing Analysis, By Virus Type
5. Global Viral Vector Manufacturing Market Outlook
   1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
   2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
   3. Global Viral Vector Manufacturing Market Outlook: Virus Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Virus Type, 2019 - 2024
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Virus Type, 2025 - 2032
         1. Adeno-Associated Virus (AAV) Vectors
         2. Lentiviral Vectors
         3. Adenoviral Vectors
         4. Retroviral Vectors
         5. Others
      4. Market Attractiveness Analysis: Virus Type
   4. Global Viral Vector Manufacturing Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
         1. Gene Therapy
         2. Vaccine Development
         3. Cancer Therapy
         4. Research & Development
         5. Others
      4. Market Attractiveness Analysis: Application
   5. Global Viral Vector Manufacturing Market Outlook: End-user
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025 - 2032
         1. Biotechnology & Pharmaceutical Companies
         2. Contract Development & Manufacturing Organizations (CDMOs)
         3. Academic & Research Institutes
      4. Market Attractiveness Analysis: End-user
6. Global Viral Vector Manufacturing Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
   3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
7. North America Viral Vector Manufacturing Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Virus Type
      3. By Application
      4. By End-user
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Virus Type, 2025 - 2032
      1. Adeno-Associated Virus (AAV) Vectors
      2. Lentiviral Vectors
      3. Adenoviral Vectors
      4. Retroviral Vectors
      5. Others
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
      1. Gene Therapy
      2. Vaccine Development
      3. Cancer Therapy
      4. Research & Development
      5. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Biotechnology & Pharmaceutical Companies
      2. Contract Development & Manufacturing Organizations (CDMOs)
      3. Academic & Research Institutes
   7. Market Attractiveness Analysis
8. Europe Viral Vector Manufacturing Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Virus Type
      3. By Application
      4. End-user
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Virus Type, 2025 - 2032
      1. Adeno-Associated Virus (AAV) Vectors
      2. Lentiviral Vectors
      3. Adenoviral Vectors
      4. Retroviral Vectors
      5. Others
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
      1. Gene Therapy
      2. Vaccine Development
      3. Cancer Therapy
      4. Research & Development
      5. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Biotechnology & Pharmaceutical Companies
      2. Contract Development & Manufacturing Organizations (CDMOs)
      3. Academic & Research Institutes
   7. Market Attractiveness Analysis
9. East Asia Viral Vector Manufacturing Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Virus Type
      3. By Application
      4. By End-user
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Virus Type, 2025 - 2032
      1. Adeno-Associated Virus (AAV) Vectors
      2. Lentiviral Vectors
      3. Adenoviral Vectors
      4. Retroviral Vectors
      5. Others
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
      1. Gene Therapy
      2. Vaccine Development
      3. Cancer Therapy
      4. Research & Development
      5. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Biotechnology & Pharmaceutical Companies
      2. Contract Development & Manufacturing Organizations (CDMOs)
      3. Academic & Research Institutes
   7. Market Attractiveness Analysis
10. South Asia & Oceania Viral Vector Manufacturing Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Virus Type
       3. By Application
       4. By End-user
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. India
       2. Southeast Asia
       3. ANZ
       4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Virus Type, 2025 - 2032
       1. Adeno-Associated Virus (AAV) Vectors
       2. Lentiviral Vectors
       3. Adenoviral Vectors
       4. Retroviral Vectors
       5. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
       1. Gene Therapy
       2. Vaccine Development
       3. Cancer Therapy
       4. Research & Development
       5. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
       1. Biotechnology & Pharmaceutical Companies
       2. Contract Development & Manufacturing Organizations (CDMOs)
       3. Academic & Research Institutes
    7. Market Attractiveness Analysis
11. Latin America Viral Vector Manufacturing Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Virus Type
       3. By Application
       4. By End-user
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Virus Type, 2025 - 2032
       1. Adeno-Associated Virus (AAV) Vectors
       2. Lentiviral Vectors
       3. Adenoviral Vectors
       4. Retroviral Vectors
       5. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
       1. Gene Therapy
       2. Vaccine Development
       3. Cancer Therapy
       4. Research & Development
       5. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
       1. Biotechnology & Pharmaceutical Companies
       2. Contract Development & Manufacturing Organizations (CDMOs)
       3. Academic & Research Institutes
    7. Market Attractiveness Analysis
12. Middle East & Africa Viral Vector Manufacturing Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Virus Type
       3. By Application
       4. By End-user
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Virus Type, 2025 - 2032
       1. Adeno-Associated Virus (AAV) Vectors
       2. Lentiviral Vectors
       3. Adenoviral Vectors
       4. Retroviral Vectors
       5. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
       1. Gene Therapy
       2. Vaccine Development
       3. Cancer Therapy
       4. Research & Development
       5. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
       1. Biotechnology & Pharmaceutical Companies
       2. Contract Development & Manufacturing Organizations (CDMOs)
       3. Academic & Research Institutes
    7. Market Attractiveness Analysis
13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Thermo Fisher Scientific Inc.
          1. Overview
          2. Segments and Deployments
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Lonza Group AG
       3. Merck KGaA
       4. Catalent, Inc.
       5. Sartorius AG
       6. Oxford Biomedica plc
       7. FUJIFILM Diosynth Biotechnologies
       8. Charles River Laboratories International, Inc.
       9. WuXi Biologics (Cayman) Inc.
       10. AGC Biologics
       11. Novartis AG
       12. Takara Bio Inc.
       13. Aldevron, LLC
       14. Batavia Biosciences B.V.
       15. Resilience
14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations